Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fospropofol disodium vs midazolam for sedation in mechanically ventilated EICU patients
ChiCTR2600125472Phase 4Not yet recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- May 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fospropofol disodium in respiratory failure, Infection, psychological trauma and 3 more (2 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoints: Response Rate of Achieving Target Sedation and Wake-Up Time. Planned start May 2026; status: not yet recruiting.
02
Drugs
fospropofol disodium
03
Conditions
respiratory failureInfectionpsychological traumaShockpost-cardiac arrest syndrome (PCAS)
Beyond the preview
Go deeper on ChiCTR2600125472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125472.